Cabot Foot Clinic Podiatrist Medicare: Medicare Enrolled Practice Location: 3065 Highway 367 S, Suite 11, Cabot, AR 72023 Phone: 501-941-3797 Fax: 501-941-7760 |
News Archive
Yesterday the American Medical Association's House of Delegates approved a resolution introduced by the American College of Surgeons and other medical societies to train more professional first responders (i.e., police and firefighters) and civilians as immediate responders in the essential techniques of bleeding control and to place bleeding control kits (containing tourniquets, pressure bandages, hemostatic dressings, and gloves) with first responders.
Viron Therapeutics Inc. today announced that the results of Viron's Phase 2a trial for VT-111 were published today in Circulation: Cardiovascular Interventions. In the study led by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, VT-111, also known as Serp-1, met both its primary and secondary endpoints of safety and biological activity in Acute Coronary Syndrome patients receiving coronary stents.
A new study from Georgia Tech shows that when patients with macular degeneration focus on using another part of their retina to compensate for their loss of central vision, their brain seems to compensate by reorganizing its neural connections.
Micro Interventional Devices, Inc. has completed enrollment in its Secure Transapical Access and Closure Study. STASIS is a non-randomized, multi-center, CE-Mark study, evaluating the safety and performance of Permaseal the world's first automated direct myocardial ventricular access and closure technology especially designed for use in transcatheter valve replacement procedures (TAVR and TMVR).
› Verified 6 days ago